102 related articles for article (PubMed ID: 37052279)
1. Development and internal validation of the survival time risk score in patients treated for oesophageal cancer with palliative intent in South Africa.
Ferndale L; Ayeni OA; Chen WC; Aldous C; Thomson SR
S Afr J Surg; 2023 Mar; 61(1):66-74. PubMed ID: 37052279
[TBL] [Abstract][Full Text] [Related]
2. Oesophageal cancer in Area 2 of Kwazulu-Natal: predictors of late presentation.
Ferndale L; Sartorius B; Aldous C; Thomson SR
S Afr J Surg; 2019 Jun; 57(2):4-9. PubMed ID: 31342677
[TBL] [Abstract][Full Text] [Related]
3. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer.
Sunde B; Lindblad M; Malmström M; Hedberg J; Lagergren P; Nilsson M
BMC Cancer; 2021 Nov; 21(1):1277. PubMed ID: 34836512
[TBL] [Abstract][Full Text] [Related]
5. Patient and tumour characteristics as prognostic markers for oesophageal cancer: a retrospective analysis of a cohort of patients at Groote Schuur Hospital.
Dandara C; Robertson B; Dzobo K; Moodley L; Parker MI
Eur J Cardiothorac Surg; 2016 Feb; 49(2):629-34. PubMed ID: 25870217
[TBL] [Abstract][Full Text] [Related]
6. Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
Bigot F; Castanon E; Baldini C; Hollebecque A; Carmona A; Postel-Vinay S; Angevin E; Armand JP; Ribrag V; Aspeslagh S; Varga A; Bahleda R; Menis J; Gazzah A; Michot JM; Marabelle A; Soria JC; Massard C
Eur J Cancer; 2017 Oct; 84():212-218. PubMed ID: 28826074
[TBL] [Abstract][Full Text] [Related]
7. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
[TBL] [Abstract][Full Text] [Related]
8. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
[TBL] [Abstract][Full Text] [Related]
9. Gender Differences in Oesophageal Squamous Cell Carcinoma in a South African Tertiary Hospital.
Ferndale L; Aldous C; Hift R; Thomson S
Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32998198
[TBL] [Abstract][Full Text] [Related]
10. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care.
Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W
J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054
[No Abstract] [Full Text] [Related]
11. Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation.
Bergquist H; Johnsson A; Hammerlid E; Wenger U; Lundell L; Ruth M
Aliment Pharmacol Ther; 2008 Mar; 27(5):385-95. PubMed ID: 18081735
[TBL] [Abstract][Full Text] [Related]
12. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
13. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
14. Prognostic models of survival in patients with advanced incurable cancer: the PiPS2 observational study.
Stone P; Kalpakidou A; Todd C; Griffiths J; Keeley V; Spencer K; Buckle P; Finlay DA; Vickerstaff V; Omar RZ
Health Technol Assess; 2021 May; 25(28):1-118. PubMed ID: 34018486
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second-line palliative chemotherapy.
Hsu CC; Liu KH; Chang PH; Chen PT; Hung CY; Hsueh SW; Yeh KY; Chen YY; Lu CH; Hung YS; Chou WC
J Gastroenterol Hepatol; 2020 Oct; 35(10):1694-1703. PubMed ID: 31711261
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Factors Associated with Palliative Care Utilization among Hospitalized Patients with Esophageal Cancer in the United States.
Jackson I; Jackson N; Etuk A
J Palliat Care; 2023 Apr; 38(2):192-199. PubMed ID: 35837723
[No Abstract] [Full Text] [Related]
17. Palliative stenting for oesophagogastric cancer: tumour and host factors and prognosis.
Park JH; Woodley N; McMillan DC; Glen P
BMJ Support Palliat Care; 2019 Sep; 9(3):332-339. PubMed ID: 29574423
[TBL] [Abstract][Full Text] [Related]
18. Palliative Prognostic Index Validation in Hospitalized Advanced Cancer Patients in Indonesia Tertiary Hospitals.
Shatri H; Prasetyaningtyas A; Putranto R; Rinaldi I
Acta Med Indones; 2021 Oct; 53(4):442-449. PubMed ID: 35027491
[TBL] [Abstract][Full Text] [Related]
19. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study.
Miura T; Matsumoto Y; Hama T; Amano K; Tei Y; Kikuchi A; Suga A; Hisanaga T; Ishihara T; Abe M; Kaneishi K; Kawagoe S; Kuriyama T; Maeda T; Mori I; Nakajima N; Nishi T; Sakurai H; Morita T; Kinoshita H
Support Care Cancer; 2015 Nov; 23(11):3149-56. PubMed ID: 25777319
[TBL] [Abstract][Full Text] [Related]
20. Identifying prognostic factors for survival in advanced cancer patients: a prospective study.
Lam PT; Leung MW; Tse CY
Hong Kong Med J; 2007 Dec; 13(6):453-9. PubMed ID: 18057434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
